Purpose: To present early results with the Treovance aortic stent-graft in the treatment of abdominal aortic aneurysms (AAAs). Methods: Between October 2013 and January 2016, 35 consecutive AAA patients (mean age 74±7.7 years; 32 men) were treated with Treovance. The maximum diameter of the treated AAA was 60±9 cm. Nine (25%) patients presented with concomitant iliac aneurysms. Seven (20%) AAAs had infrarenal neck angulation >60°. The infrarenal neck length and diameter were 21.6±12.6 mm and 25.7±4.6 mm, respectively. Sixteen (45%) AAAs had a reversed tapered neck contour. Six (17%) and 9 (25%) patients showed severe or moderate iliac tortuosity, respectively. Primary endpoints were endoleak, reintervention, and aneurysm-related death. Results: Primary technical success was 94% due to 2 intraoperative type Ia endoleaks, which were successfully treated with a proximal aortic extension (100% assisted primary technical success). Local dissection was encountered in 5 (7%) of 70 femoral artery access sites in 4 patients. During a mean 12-month follow-up (range 6-24), clinical success was 97%. No type I or III endoleak, death, AAA rupture, open conversion, or device-related serious adverse events were documented. Four type II endoleaks were detected; one resolved spontaneously at 12 months and 2 remained stable, while one associated with AAA sac enlargement was treated successfully with embolization of the lumbar arteries (3% reintervention rate). Conclusion: Treovance shows accurate deployment even through angulated and tortuous iliac vessels and presents satisfactory conformability in highly angulated necks with acceptable clinical results. Future development to lower the profile and increase the flexibility of its delivery system will enhance its applicability in cases of narrow access vessels.
Introduction
Endovascular aneurysm repair (EVAR) is considered the treatment of choice in the majority of abdominal aortic aneurysms (AAA) since it is associated with low perioperative morbidity and mortality and a shortened hospital stay. 1, 2 Over the past decade, there has been a widespread increase in the use of EVAR worldwide: In the United States, 74% of the total number of AAA repairs are performed with EVAR. 3 Significant modifications and developments in the design of aortic endografts during the EVAR evolution enhanced their mechanical reliability and thus their applicability and clinical performance in the long term. 4, 5 Significant variations exist in the sealing and/or fixation modes. Some endografts have passive fixation using their radial support and columnar strength, while others present active fixation with pins, hooks, and barbs to reduce devicerelated complications with respect to endoleaks. The great variety of commercially available endografts provides multiple choices, taking into consideration the intrinsic mechanical properties and technical characteristics of each device when selecting the appropriate endograft for a specific AAA anatomy.
The Treovance Abdominal Stent Graft System (Bolton Medical, Barcelona, Spain) is a trimodular endograft composed of a series of self-expanding serpentine nitinol stents sutured to a tightly woven polyester graft fabric. 6 The endograft received Conformité Européenne mark in 2013. There is only limited experience to date reporting the technical success and short-term efficacy with the device. [6] [7] [8] Hence, the aim of this study was to document our initial experience with the Treovance abdominal aortic stent-graft system.
Methods

Study Design
Patients were selected for EVAR based on standard aneurysm criteria 9, 10 assessed from computed tomography angiography (CTA) scans. CTA images were acquired on a 64-slice CT scanner operating under the following settings: 260 mAs, 120 kVp, 1.5-mm slice thickness, 50-cm field of view, 64×0.625-mm collimation, and a 0.984:1 pitch ratio. The acquired datasets were transferred to dedicated software (3Mensio Medical Imaging B.V., Bilthoven, the Netherlands) and processed for angulation measurements using a center lumen line and 3-dimensional (3D) reconstruction, as described elsewhere. 11, 12 The 3D reconstruction was turned 360° perpendicular to the lumen centerline, and the sharpest angle of the centerline was considered as the angle of the axis. 13 In addition to standard morphological suitability for EVAR, other selection criteria were life expectancy >24 months, the ability to provide written informed consent, and the willingness to comply with the follow-up schedule. Anatomical criteria for treatment according to the Treovance instructions for use (IFU) included (1) juxtarenal aortic neck angulation ≤60° with a proximal landing zone ≥10 mm and an inside aortic diameter of 17 to 32 mm or (2) proximal neck angulation 60° to 75° with a proximal landing zone ≥15 mm and an inside aortic diameter of 17 to 30 mm. Accordingly, the minimum iliac landing zone was (1) 10 mm when the lumen diameter ranged from 8 to 13 mm or (2) 15 mm with an inner diameter range of 14 to 20 mm. 6 Iliac tortuosity was determined along the entire iliac axis length and was considered mild when there was ≥1 angulation of 45° to 90°, moderate with 1 angulation ≥90°, and severe with >2 angulations ≥90°. Exclusion criteria were iliac stenoses that could not be crossed by a guidewire, active systemic infection, ruptured or mycotic AAA, acute or chronic renal failure with creatinine >2.5 mg/dL, prior AAA repair, untreatable allergy or sensitivity to contrast media, or atheroma, extensive thrombus (>2 mm), or calcification in >50% of the cross-sectional proximal infrarenal neck within 10 to 15 mm (depending on the infrarenal neck angulation) of the lowermost renal artery.
Device Characteristics
The technical characteristics and deployment technique of the Treovance device have been presented extensively in the literature. 6 Unlike other endografts that have either suprarenal or infrarenal fixation, Treovance provides 2 levels of fixation with caudally oriented suprarenal and infrarenal barbs on the top and bottom, respectively, of the proximal bare stent (10-mm long). The suprarenal barbs remain covered by the clasping system until the main body is completely deployed. The infrarenal barbs remain concealed in the valley of the first covered stent to allow safe repositioning of the device both cranially and caudally until the proximal bare stent is released.
The diameter of the main body ranges from 20 to 30 mm in 2-mm increments and reaches a maximum 36-mm diameter in 3-mm increments. The bifurcated main body comes in 3 lengths (proximal edge of fabric to contralateral limb stump): 80, 100, and 120 mm ( Figure 1A ). The length of the overlap between the main body and the limb extensions is highly adjustable (between 2 and 6 cm for the ipsilateral limb and 2 and 3 cm for the contralateral limb). Another exclusive characteristic of Treovance is the unique "lock-stent" mechanism in the limb gates. The 5 rounded, intraluminally facing barbs at the caudal end of the second most distal stent secure modular fixation and counteract displacement forces predisposing to dissociation and type III endoleak. The delivery system is characterized by a turning knob for gradual and precise deployment of the stent-graft, a caudally located grip for release of the clasping mechanism that restrains the proximal stent, and a detachable sheath that stays in place after withdrawal of the delivery system and facilitates angiography and insertion of the iliac limb.
The length of the iliac limbs expands from 80 to 160 mm (20-mm increments) and distal diameters come in a range of 8 to 24 mm. All limbs fit all main bodies (standard central diameter of 15 mm). The Treovance delivery system comes in a low-profile 19-F (outer diameter) version for a 30-to 36-mm main body or an 18-F model for 20-to 28-mm main bodies. The precise and gradual deployment of the main body is achieved through a turning knob ( Figure 1B ) in the delivery system. The delivery system contains a detachable sheath that can be separated from the main handle, enabling introduction of the ipsilateral limb extension while facilitating intraoperative angiography without sheath exchange.
Patient Cohort
Between October 2013 and January 2016, 35 consecutive patients (mean age 74±7.7 years, range 55-88; 32 men) were treated with the Treovance aortic stent-graft for intact AAAs at 2 academic Greek vascular centers performing 50 to 60 EVAR operations per year. Assessment of comorbidities was according to the Society for Vascular Surgery/American Association for Vascular Surgery medical comorbidity grading system. 9 Eight of the 35 patients have been reported previously. 8 The characteristics of the patients are outlined in Table 1 . The infrarenal neck length and diameter were 21.7±12.6 mm and 25.7±4.6 mm, respectively. The centerline length from the lowest renal artery to the aortic bifurcation was 115.2±16.0 mm. Sixteen (45%) AAAs had a reversed tapered neck contour. Seven (20%) patients presented with infrarenal neck angulation >60°; 6 of them had a neck length ≥15 mm in compliance with the Treovance IFU ( Figure 2 ), whereas 1 patient had an infrarenal neck >60° and neck length of 10 mm. Six (17%) and 9 (25%) patients showed severe or moderate iliac tortuosity, respectively. Nine (25%) patients had concomitant common iliac artery (CIA) aneurysms (ie, diameter ≥20 mm; 7 bilateral). The median aneurysm diameters of the right and left CIAs were 32.7 mm (range 22-70) and 26.3 mm (range 20-36), respectively.
EVAR Procedure
The endograft was oversized by 10% to 20% with respect to the diameter of the AAA neck and iliac landing zones. The access side for the main body was decided considering the diameter, tortuosity, angulation, and calcification of the access vessels, as well as taking into account the difficulty of catheterization caused by the presence of iliac aneurysms. Furthermore, the distribution of intraluminal thrombus and the curvature of the lumen centerline were considered in order to avoid deployment of the contralateral iliac limb too close to the aneurysm wall or to the intraluminal thrombus, making the contralateral cannulation difficult. Overstenting of the internal iliac artery was preferred only if there was no adequate sealing zone distal to the CIA or if bell-bottom limbs could not be used.
All procedures were performed by a vascular/endovascular surgeon in the operating theatre with a portable C-arm (Philips BV Endura 2.2.3; Philips Medical Systems, Eindhoven, the Netherlands). Spinal anesthesia was used in 23 (65%) cases. Ten (28%) patients underwent general anesthesia while the remaining 2 (7%) had local anesthesia.
Surgical femoral exposure was used for vascular access; all patients received 10,000 units of heparin after sheath insertion. The device's main body was advanced and deployed in the appropriate anatomical position, followed by proximal clasping release, cannulation of the contralateral limb gate, and deployment of the iliac limbs. Molding balloon angioplasty of the proximal and distal landing zones, as well as along the length of the iliac extensions including the modular overlap zones, was performed 
Definitions and Outcomes
Primary technical success was defined as successful delivery and deployment of the device with no evidence of type I or III endoleak, limb occlusion, hemodynamically significant stenosis on completion angiography, or need for any unplanned surgical or endovascular interventions on the endograft within the 24 hours. Assisted primary technical success referred to aneurysm exclusion and a patent graft after an adjunctive intraoperative procedure (eg, cuff deployment). Clinical success was considered the absence of aneurysm expansion >5 mm, type I or III endoleak, aneurysm rupture, graft migration, limb occlusion, aneurysm-related mortality, secondary intervention, or surgical conversion. 9, 10 Continuous data are presented as the means ± standard deviation or median (range) for nonparametric variables (normal distribution evaluated using the KolmogorovSmirnov test); categorical data are given as the counts (percentage). Statistical analyses were performed using STATISTICA software (version 7.0; StatSoft, Tulsa, OK, USA). (Table 2) , during which a median 120 mL (range 25-200) of contract was administered over a median 25 minutes (range 12-35) of fluoroscopy time. The most used main body sizes were 36 (n=8), 28 (n=8), and 33 mm (n=7), followed by 24 (n=5), 30 (n=3), 26 (n=2), and 22 (n=1) mm. All patients tolerated the procedure well.
Results
Mean operation time was 90±15 minutes
Primary technical success was 94% due to 2 intraoperative Ia endoleaks, which were successfully treated with a proximal aortic cuff (100% assisted primary success). Local dissection was encountered in 5 femoral artery access sites in 4 patients. Perfusion was restored with flap excision, tacking sutures, and a vein patch (2 vessels), graft interposition (1 vessel), or graft patch (2 vessels). One of these patients had occlusion of the superficial femoral artery, but no prior iliofemoral lesion. This patient had a secondary open repair (arterioplasty with synthetic graft patching) 1 month post EVAR due to intermittent claudication.
Eight of the 9 patients (12 limbs) with concomitant CIA aneurysms had an adequate distal landing zone suitable for bell-bottom iliac limbs. Distal sealing in the external iliac artery was necessary in 3 patients (bilaterally in 1 patient who had only 1 patent hypogastric artery preoperatively). Only 1 sole patent internal iliac artery was coil embolized 4 weeks before EVAR (Figure 3 ) because overstenting of its orifice could not be achieved due to the enormous diameter of the CIA aneurysm. No patient experienced buttock claudication.
Clinical Outcomes in Follow-up
During the median 12-month follow-up (range 6-24), no endoleak type I or III, limb occlusion, graft migration, death, AAA rupture, or open conversion was documented. Four (11%) patients developed type II endoleak from the lumbar arteries. One leak resolved spontaneously after 12 months and 2 others were not associated with sac enlargement. The fourth type II endoleak was accompanied by sac enlargement >5 mm (from 7.5 to 8 cm), necessitating endovascular reintervention (97% clinical success rate). The pair of lumbar arteries were successfully embolized (Figure 4) , and the patient remained free of endoleak relapse and further sac enlargement through 12 months of follow-up (3% reintervention rate).
Discussion
The 5-center ADVANCE European Clinical Trial was the first to report the technical success and immediate postoperative results of the Treovance endograft in 30 patients with a mean AAA diameter of 54.2±6.5 mm. 6 Three of these patients had significant proximal neck angulation (60°-70°), whereas 11 iliac arteries were <8 mm in diameter. 6 Primary technical success was achieved in all patients without complications. Subsequently, Kahlberg et al 7 reported their single-center experience in 8 patients. Three patients had moderate or severe iliac artery tortuosity, while 5 had moderate or severe calcification of the access vessels. Open conversion and aortobifemoral bypass due to graft limb thrombosis at 4 months was necessary in 1 patient. More recently, our group reported its first experience with the Treovance; those 8 patients are included in the present analysis.
In the current series of 35 patients, the 2 intraoperative type Ia endoleaks were caused by inadvertent deployment below the planned site in one and false estimation of the endograft's required diameter in the other, as previously described. 8 No type Ia endoleak occurred during the followup, even in the 7 patients with angulated necks ≥60°. One should bear in mind the unique feature of Treovance with respect to the caudally oriented suprarenal and infrarenal barbs on the top and bottom of the proximal stent, which is partially overlapped with the first covered stent. 6 It is the extra infrarenal barbs that are designed to hook in place in cases of significant infrarenal neck angulation, providing extra fixation. Indeed, Rahmani et al 14 performed benchmark tests in fresh bovine aortas to assess the pullout forces that tend to dislodge different aortic endografts of various fixation designs. In accordance with results from computational studies, 15 Rahmani et al 14 confirmed that increasing infrarenal angulation decreases the forces responsible for endograft migration and dislodgment. In this study, Treovance exhibited very strong fixation. 14 Apart from neck angulation, large neck (inlet) diameters have also been associated with higher displacement forces and thus greater predisposition to migration. 16 In addition, de Bock et al 17 showed that a 10% to 20% central oversizing of a nitinol-based endograft is associated with significant asymmetry of forces applied onto the infrarenal neck surface, predisposing to loss of sealing. Therefore, in necks with severe angulation or large diameter, as in 8 of our cases, the combination of suprarenal and infrarenal fixation may prove beneficial in preventing migration. The use of trimodular endografts is considered beneficial since their long limbs preclude or reduce the rate of using extra limb extensions (thus raising the cost) to complete the procedure safely, while the size and configuration of iliac limbs are ideal for performing the bell-bottom technique in cases of large distal landing zones.
The 9 patients with CIA aneurysms in our cohort had adequate distal landing zones suitable for either bell-bottom iliac limbs or sealing in the external iliac artery (overstenting or coil embolization of the hypogastric artery). The durability of distal landing in cases of aneurysmal CIAs has been only recently addressed in the literature. 18, 19 Griffin et al 18 compared 70 aneurysmal CIA landing zones (diameter 24.8±4.5 mm) with 25 normal EVAR subjects over a median follow-up of 39.2 months. Although the rate of landing zone diameter expansion was significantly greater over time (0.09 vs 0.03 mm/month, p<0.001), no type Ib endoleak developed in either group. Only 2 cases of limb dilatation and retraction were recorded, leading to the use of an iliac limb extension to avoid impeding loss of distal sealing (type Ib endoleak). In a similar study, Kirkwood et al 19 suggested that the degree of iliac limb oversizing is of crucial importance to significant future dilatation of these aneurysmal landing zones. Therefore, it is suggested that oversizing of stent-grafts in aneurysmal iliac vessels should not exceed 5% to 10% (maximum), as was the case in our cohort.
The large diameters and morphology of bell-bottom iliac limbs have been associated experimentally with high displacement forces, the magnitude of which correlates significantly with the degree of the sideways movement of the iliac limbs. 20 Therefore, the locking barbs that engage the limb extensions on the Treovance endograft effectively counteract displacement forces. They seem well suited for such bell-bottom cases where extra intramodular fixation is needed to avoid disconnection and type III endoleak. 21 The hydrophilic coating and flexibility of the Treovance delivery system ensured easy advancement through tortuous iliac vessels. There was an intimal tear needing repair in 5 femoral sites even though all access vessels had a diameter ≥7 mm, as suggested in the literature to minimize potential access complications. 22 Since the vessels were neither calcified nor very narrow, such intimal damage could be attributed to a combination of the rather large sheath size (19-F for the main body and 15-F for the contralateral limb extension) with prolonged maintenance onsite of the detachable sheath after its separation from the main handle, although similar events were not recorded in other studies. 6, 7 Nonetheless, it is our impression that further downsizing of the delivery system's profile and gentle rotational maneuvers during advancement and withdrawal will mitigate these access-related complications.
The length of the endograft's main body was chosen so that the contralateral limb stump could approach the aortic bifurcation as closely as possible. Although the time for contralateral cannulation was not recorded, it is our strong belief that such short distance markedly facilitated the cannulation of the contralateral limb.
Limitations
Although our cohort included some AAAs with challenging and severely angulated necks, the small number of these cases prohibits generalization of our very positive impression to such anatomies. Obviously, larger clinical studies with longer follow-up are needed to ensure the endograft's satisfactory clinical performance. Moreover, since the vast majority of patients were male, additional studies are needed to ensure the endograft's applicability and efficiency in female patients in whom the iliac diameters are narrower.
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Conclusion
The Treovance aortic stent-graft presents easy navigation even through angulated and tortuous iliac vessels and provides accurate deployment, secure proximal seal, optimal fixation, and conformability in angulated necks. Early results are promising, with excellent safety and effectiveness. The performance of the device in challenging anatomies, such as short, wide, or extremely angulated necks, merits further attention. Lowering the profile and increasing the flexibility of its delivery system can enhance its applicability in cases of narrow access vessels.
